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Adaptive strategies permit survival during an extended period
without food and water. This evolution required several inte-
grated responses to accommodate many, and seemingly conflict-
ing, physiological demands. We believe that the setting of pro-
longed starvation provides an ideal opportunity to learn many
lessons that will help clinicians understand integrative renal
physiology, with the ultimate aim of applying new insights at the
bedside. We recognize that at times speculations will take us
beyond the absolute database, and these will be highlighted. In
addition, new information from our own data will be provided
where data are not available in the literature. Our emphasis in this
review will be on how these physiologic responses might be
integrated, rather than a detailed description of the different
transport systems that are involved.
INTEGRATED PHYSIOLOGY OF PROLONGED FASTING
Central issue, providing the brain with an energy source
We begin our analysis of prolonged fasting (defined as the total
absence of exogenous energy and protein for at least one week)
with a consideration of what is probably its most fundamental
element, the need to provide the brain with enough adenosine
triphosphate (ATP) from the endogenous storage fuel, triglycer-
ides in adipose tissue. Ketoacids [mainly b-hydroxybutyrate (b-
HB2)] rather than long-chain fatty acids are the major fat-derived
brain fuel because the latter do not cross the blood-brain barrier
at a significant rate [reviewed in 1–3]. A high level of ketoacid
anions in plasma is needed, however, so that the brain can extract
and oxidize enough of this fuel to displace glucose and thereby
mitigate the requirement for excessive catabolism of body protein
[2]. The apparent disadvantage of ketonemia is the obligate, or
seemingly obligate, daily urinary excretion of ketoacid anions (150
mmol/day) [2, 4–7]. Moreover, a degree of metabolic acidosis is
maintained throughout fasting; the reason(s) why metabolic aci-
dosis persists will be considered below.
Issues related to acid-base balance
Acid-base balance is maintained during ketoacidosis of pro-
longed fasting because the rate of production of H1 is matched by
their rate of removal. The rate of production of ketoacids seems
to be limited by the rate of turnover of ATP in hepatocytes, with
a near maximum rate of close to 1500 mmol/day [8, 9]. Most
(80%) of these ketoacids are metabolized to yield neutral end-
products such as CO2 1 H2O in the brain (750 mmol/day) and the
kidneys (250 mmol/day) [2, 10, 11]. Although a small proportion
of ketoacid anions (;150 mmol/day) are excreted in the urine,
acid-base balance is achieved because they are excreted primarily
as their ammonium (NH4
1) salts [reviewed in 9, 12]. Hence, it is
clear that there must be sustained stimuli for the enhanced
production and excretion of NH4
1, and in fact, two are present:
metabolic acidosis [13] and potassium (K1) depletion [14]. Nev-
ertheless, the rate of excretion of NH4
1 is considerably lower
during prolonged fasting than in normal subjects given a large and
chronic load of NH4Cl (Fig. 1). Therefore, there appears to be a
limit set on the rate of excretion of NH4
1 during prolonged
fasting, that may be due to a lower rate of production of NH4
1
and/or a lower rate of transfer of NH3 to the final urine. Both
elements will be analyzed in the following paragraphs.
Production of ammonium. There are several reasons to suspect
why the production of NH4
1 in the proximal convoluted tubule
(PCT) could be relatively lower during ketoacidosis. Since the
maximum rate of NH4
1 production in cells of the PCT is set by
the rate of turnover of ATP in these cells [15], there is a
‘metabolic competition’ between fuels to provide the ATP needed
to perform renal work [16], primarily the reabsorption of filtered
Na1 [17]. Lemieux et al [18] showed that the provision of
ketoacids (a non-glutamine fuel) to dogs with chronic metabolic
acidosis induced by feeding of NH4Cl, diminished renal NH4
1
production. In addition to this fuel competition, the lower glo-
merular filtration rate (GFR) observed during prolonged fasting
[19] decreases the rate of filtration and thereby the rate of
reabsorption of Na1 and hence the need to regenerate as much
ATP in the PCT. Further, a lower plasma glutamine level could
also contribute to the reduced rate of renal ammoniagenesis [20,
21].
In summary, it seems that the lower rate of excretion of NH4
1
during prolonged fasting could be due to a relatively lower rate of
ammoniagenesis. This mechanism, however, is not likely to pro-
vide a physiological control mechanism that is precise enough to
lead to the virtual matching of the rates of excretion of NH4
1 and
ketoacid anions, which is required to maintain acid-base balance
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and avoid the loss of the cations sodium (Na1) and K1 in the
urine. Therefore, other control mechanisms for the excretion of
NH4
1 probably operate in this setting.
Transfer of NH3 into the urine. An important factor that
influences the transfer of NH3 from the medullary interstitial fluid
to the urine is the secretion of H1 in the distal nephron. This
lowers the luminal [NH3] in the collecting duct and thereby allows
for passive diffusion of NH3 down its concentration difference
[22]. In patients with chronic metabolic acidosis and a low rate of
excretion of NH4
1, the basis for low NH4
1 excretion can be
deduced from the urine pH [reviewed in 23, 24]. A low value for
the urine pH (, 5.3) suggests a defect in NH3 availability in the
renal medullary interstitium, whereas a high urine pH (. 6.0)
suggests that the limiting step is distal H1 secretion (equation 1).
H1 1 NH3 7 NH41 (Eq. 1)
The pH of the urine undergoes well-characterized changes
during prolonged fasting [4]. In the first few days, the urine pH is
close to 5.3, but it then rises to close to 6.0 over the next several
days (Table 1), a time when the rate of excretion of NH4
1 is at its
peak. We interpret these data as follows. While acidemia stimu-
lates distal H1 secretion promptly, there is a lag period before
renal ammoniagenesis is augmented [13]. Hence, the increase in
distal H1 secretion is not matched initially by increased availabil-
ity of NH3, the urine pH is low and the rate of excretion of NH4
1
is limited by the availability of NH3. After several days of fasting,
the rate of excretion of NH4
1 rises, but nevertheless remains
substantially lower than in normal subjects given a chronic and
large load of NH4Cl (Fig. 1). Since the urine pH is close to 6.0
after NH4 Cl loading in the normal and fasted subjects (Fig. 1),
this suggests that a lower rate of distal H1 secretion is not
responsible for this relatively lower rate of NH4
1 excretion.
H1 secretion in the distal nephron is mediated primarily by a
vacuolar H1-ATPase [25, 26] and also by an H1/K1 ATPase [27];
a Na1/H1 ion exchanger may also play a role [28]. Distal H1
secretion by the H1-ATPase is an electrogenic process which
tends to create a lumen positive voltage. Because the lumen of the
medullary collecting duct only maintains a small positive voltage
[26], for H1 secretion to continue, either an anion [like chloride
(Cl2)] must be secreted or a cation like Na1 must be reabsorbed.
Since it is known that natriuresis occurs early in fasting and that
the rate of excretion of Na1 declines markedly thereafter [29–32],
H1 secretion may be limited by a low distal delivery of Na1. To
test this hypothesis, we studied subjects who had fasted for two
weeks; their urine pH was measured before and after an acute
infusion of Na1. There was a marked fall in the urine pH in
conjunction with the rise in Na1 excretion (Fig. 2) [33, 34]. These
data suggest that distal H1 secretion was now limited by distal
Na1 delivery. Having this limit on distal H1 ion secretion by
delivery of Na1 could also explain the fact that the acute
administration of NH4Cl to fasted subjects that caused a more
severe degree of acidemia did not result in a significant decline in
the urine pH or rise in the rate of excretion of NH4
1 [4].
If a low delivery of Na1 does limit distal H1 secretion and
thereby the rate of excretion of NH4
1 during prolonged fasting, a
higher rate of excretion of NH4
1 would be expected when distal
delivery of Na1 rose. Notwithstanding, there was no appreciable
rise in NH4
1 excretion when the urine pH fell when either NaCl
[33] or Na1 lactate2 [34] was given. Therefore, the lower than
expected rate of production of NH4
1 is the factor that is actually
rate-limiting for this process.
It is important to recall that the augmented excretion of NH4
1
during prolonged fasting imposes a metabolic disadvantage to
survival, the catabolism of lean body mass to provide glutamine,
the substrate for ammoniagenesis [35]. Hannaford et al [6] have
shown that diminishing this excretion of NH4
1 by administering
NaHCO3 plus KCl could spare an appreciable quantity of lean
body mass per day in prolonged fasting. Given this ‘extra’ protein
catabolism imposed by the need to excrete NH4
1, having a lower
Fig. 1. Effect of a chronic NH4Cl load on NH41 excretion in normal
subjects and during prolonged fasting. The data for total fasting (N 5 5)
are taken from the study of Kamel et al [36] and the data for the fed state
(N 5 30) with an NH4Cl load are taken from Madison and Seldin [78].
The rate of excretion of NH4
1 is shown on the y axis and is in mmol/hr 6
SEM; the supplement of NH4Cl lowered the plasma [HCO3
2] to 13 mM
during chronic fasting and to 21 mM in the fed subjects. The values for the
urine pH are shown above each column; the SEM for each urine pH is 0.2
units.
Table 1. Values for urate, volume and pH in urine in prolonged fasting
Day 0 Day 3 Day 7
pH 5.9 5.3 5.9
‘Non-urea’ osmoles mOsm/day 450 600 300
‘Non-urea’ osmolality mOsm/liter 600 600 600
Expected flow rate liters/day 0.75 1.0 0.50
Total urate mg/day 450 236 316
Uric acid mg/liter 120 118 122
For details, see text. The values in the fasted subjects were derived from
the following references [4, 19, 29, 30, 77]. The ‘non urea’ osmoles were
derived from the rate of excretion of electrolytes on each of these days and
the ‘non-urea osmolality’ is the maximum value with water deprivation and
assigned a value of 600 mosm/l for ease of calculation [75]. The expected
minimum urine flow rate is the number of ‘non-urea’ osmoles excreted per
day divided by the ‘non-urea osmolality’. The concentration of uric acid
was calculated taking into consideration its pK and urine volume.
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rate of NH4
1 excretion seems to be a reasonable defense mech-
anism, yet it results in an appreciable degree of metabolic acidosis.
Whether there might be a physiologic ‘trade-off’ here, and
whether there might be a possible advantage in maintaining a
lower concentration of bicarbonate (HCO3
2) in plasma during
prolonged fasting will be considered in the section dealing with
K1. Also, considering the metabolic cost of NH4
1 excretion, we
wondered if there might be another advantage of ensuring NH4
1
excretion; this will be discussed under the ‘water’ section.
Even with this limit on the rate of excretion of NH4
1 during
prolonged fasting, acid-base balance can be maintained if these
subjects are faced with another acid load (such as NaHCO3 loss
because of diarrhea) without increasing the rate of excretion of
NH4
1 [36]. The key to understand how H1 were eliminated is to
focus on the renal handling of the b-HB2 anion. By oxidizing
rather than excreting b-HB2, the H1 formed with it would be
removed by metabolic means (Fig. 3). Now excretion of the same
amount of NH4
1, but with Cl2 instead of b-HB2, adds new
HCO3
2 to the body and titrates the H1 load from the ingested
NH4Cl. Although the decrease in b-HB
2 excretion was partly due
to a lower filtered load, a renal mechanism was also operating
because the fractional excretion of b-HB2 was markedly reduced
to 3% [36] from the usual 15 to 20% [37] during prolonged fasting.
While the mechanism for the enhanced reabsorption of b-HB2 is
not entirely clear, the results of this study point out another
mechanism by which the kidney maintains acid-base balance,
modulation of the rate of excretion of metabolizable organic
anions [38].
Issues related to sodium balance
Obviously, with no intake of Na1, the kidney must reabsorb
virtually all the filtered Na1 to prevent a severe degree of
contraction of the extracellular fluid (ECF) volume. Quantita-
tively, the natriuresis of prolonged fasting is much larger than the
natriuresis that occurs when normal subjects have a very low
intake of NaCl. In more detail, the negative balance for Na1 is
close to 150 mmoles several days after commencing a diet that is
virtually Na1-free; very little Na1 is excreted thereafter [reviewed
in 39]. Moore-Ede et al speculated that this excretion represents
the loss of NaCl that was retained from the previous day’s intake
[40–42]. In contrast, subjects who fast for several days have a
negative balance for Na1 of close to 350 mmol [29–32]. Several
mechanisms have been implicated to account for this larger
natriuresis with fasting. One explanation is that the rate of
excretion of ketoacid anions exceeds that of NH4
1 in the first few
days of fasting, and this obligates the excretion of a cation such as
Na1 [4, 43]. Second, acidosis could augment the natriuresis
because subjects on a low salt diet given NH4Cl had a larger
natriuresis [30]. Third, this excessive natriuresis may be related to
the hormonal changes in fasting. While glucagon is considered by
some to be the ‘natriuretic hormone in fasting’ [44], an important
role for the marked decline of insulin has been suggested [45, 46].
A striking example that illustrates quantitative aspects of the
natriuresis of prolonged fasting was provided in a study by
Schloeder and Stinebaugh [47]. Obese subjects fasted for up to 14
days in a tropical environment had an extraordinarily large
natriuresis which amounted to a negative balance of close to 1000
mmol of NaCl (normal subjects have a total content of Na1 in
their ECF of only about 2000 mmol). These authors speculated
that the ‘reservoir’ of this Na1 was extra (previously) retained
NaCl, which they called ‘heat edema.’ This points out that the
natriuretic stimulus of fasting can be a profound one, and it
continues until an appreciable degree of contraction of the
‘effective’ ECF volume occurs. After this initial phase of natriure-
sis, avid Na1 retention is the rule. This antinatriuresis may even
persist and result in excessive retention of Na1 on refeeding to the
extent that edema may develop [reviewed in 31].
The large natriuresis of fasting has an obvious potentially
deleterious effect, a significantly contracted ECF volume. This
lower ECF volume, by lowering the maximum cardiac output,
could limit the ability to exercise vigorously [48, 49], with many
negative implications for survival. Therefore, humans are faced
with the challenge of defending their blood volume during
prolonged fasting. A major factor influencing the blood volume is
the red blood cell (RBC) mass. Therefore, if the deficit of Na1
could provide a stimulus to synthesize RBC, this could help
defend the vascular volume during prolonged fasting. One possi-
ble mechanism to stimulate erythrocytosis is the interaction
between erythropoietin production and angiotensin II. Angioten-
sin II rises in response to contraction of the ECF volume. By
stimulating proximal Na1 reabsorption, more oxygen consump-
tion could occur near the site of production of erythropoietin;
angiotensin II may also have a direct effect on erythropoietin
production [50]. We observed an increase in both the hemoglobin
and the hematocrit levels (13.1 6 0.26 to 13.8 6 0.20 g/dl, 39.6 6
0.96 to 41.3 6 0.64%, mean 6 SEM, N 5 11) after four weeks of
fasting (unpublished data). Part of this rise in hematocrit, how-
ever, may reflect the lower plasma volume. Nevertheless, given
the half-life of red blood cells (RBC; 127 days) and the length of
fasting (30 days), there seems to be a ‘selective’ preservation of
the RBC mass in this setting that on its own would minimize the
risk of an even lower blood volume.
Fig. 2. Effect of an acute infusion of NaCl on the urine pH during
prolonged total fasting. Data were taken from [33]. Prolonged fasted
subjects (N 5 4) received an infusion of isotonic NaCl beginning at time
0 hours and lasting six hours. Urine was collected hourly. The data from
each subject are connected by a line. The urine pH is depicted on the ‘y’
axis and time in hours is depicted on the ‘x’ axis.
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This large initial natriuresis may be a ‘trade-off’ for physiolog-
ical gains during prolonged fasting. For example, it may help
maintain a large enough urine volume early on in fasting when
antidiuretic hormone (ADH) acts (equation 2) and thereby lower
the concentration of uric acid, and as a result, minimize the risk of
its precipitation in the urine. Having a large deficit of Na1 should
also bring homeostatic mechanisms into play that lead to very avid
reabsorption of Na1 in upstream nephron segments and thereby
limit the distal delivery of Na1. The low distal delivery of Na1
may help to minimize the rate of excretion of K1. It could also be
associated with a low rate of distal H1 secretion as discussed
earlier without really compromising the rate of excretion of
NH4
1. A possible advantage, however, of this low rate of distal
H1 secretion is to have a higher urine pH, which should lessen the
likelihood of uric acid stone formation. More about this possibility
is in the section on uric acid.
Urine volume 5 # of Solutes excreted/[Solutes] in the urine
(Eq. 2)
Issues related to potassium balance
Balance data in prolonged fasting show a deficit of greater than
300 mmol of K1 [4, 51]; a modest degree of hypokalemia usually
develops if K1 supplements are not given [51]. Renal mechanisms
for conservation of K1 come into play and the daily loss of K1 is
diminished to less than 10 to 15 mmol. Notwithstanding, this takes
place in the presence of factors that might be expected to
stimulate net secretion of K1 in the distal nephron, namely, the
continuing presence of aldosterone [5, 31, 52] and the delivery of
anions that are not absorbed in the distal nephron (b-HB2) [53].
While the antinatriuretic effect of aldosterone is important during
prolonged fasting, its kaliuretic effect is clearly undesirable. This
raises the intriguing question of what is needed so that aldoste-
rone can be a NaCl-retaining hormone while avoiding its kali-
uretic action? We have alluded earlier to one possible mechanism
to limit the excretion of K1: a decreased delivery of Na1 to the
distal nephron. For this to be an effective mechanism, the [Na1]
in the luminal fluid in the cortical collecting duct (CCD) will
probably need to be less than 10 to 15 mM, the concentration that
results in half-maximal secretion of K1 in the CCD of the rat [54].
Having this as a primary control mechanism, however, could be
problematic if a need for the excretion of K1 arises (such as cell
necrosis). In fact, when NaCl was infused in fasted subjects to
increase the distal delivery of Na1 (Na1 excretion rose), there was
only a modest rise in the rate of excretion of K1 (Fig. 4) [33].
Hence, other mechanisms are probably operating to curtail the
rate of excretion of K1 during prolonged fasting.
Apart from aldosterone, the presence of HCO3
2 in the lumen
of the CCD seems to modulate net secretion of K1. This effect of
HCO3
2 is unique compared to other anions (such as sulfate) that
are not reabsorbed in the distal nephron. In fact, anions like
sulfate stimulate K1 secretion only when the luminal [Cl2] is very
low [55, 56]. HCO3
2, on the other hand, seems to stimulate the
secretion of K1 even when abundant Cl2 is present in the lumen
of the CCD. How HCO3
2 (or an alkaline luminal pH) exerts this
kaliuretic effect is not clear. It is possible that this effect may be
due to an increase in K1 ion conductance; this would be impor-
tant, however, only if the activity of the K1 channel was rate-
limiting for the secretion of K1. We have hypothesized that the
effect of HCO3
2 may be due to a decrease in the “apparent”
permeability for Cl2 in the CCD, possibly due to carbamoylation
of a Cl2 reabsorptive pathway [55]. Nevertheless, and regardless
of the mechanism, clinical disorders with excessive kaliuresis and
a high urine [K1] are often those associated with a high rate of
delivery of HCO3
2 to the CCD (such as patients with vomiting, or
those with proximal RTA treated with alkali, and patients receiv-
ing carbonic anhydrase inhibitor type of diuretics, such as acet-
azolamide) or with problems with the reabsorption of HCO3
2 in
the distal nephron (for example, patients with distal RTA).
Furthermore, in the diurnal period the highest excretion of K1 is
near 12:00 hours, which is coincident with the alkaline tide [57]. In
fact, giving the mineralocorticoid, 9-a-fludrocortisone, in the
evening did not lead to a high transtubular K1 concentration
gradient (TTKG) in humans unless NaHCO3 was also consumed
or acetazolamide was given to induce bicarbonaturia [57].
Considering the possible role of HCO3
2 as a modulator of the
rate of K1 secretion, we examined whether delivery of HCO3
2 to
Fig. 3. Elimination of an additional acid load
in prolonged fasting. Acid-base balance occurs
in prolonged fasting because all the ketoacids
produced (dashed rectangle) are removed by
metabolism to CO2 and water (dashed oval) or
excreted as their NH4
1 salts. When an
additional load (HCl in the solid oval) is given,
there is very little excretion of b-HB2. All the
b-hydroxybutyric acid is removed by metabolism
to CO2 1 H2O. The H
1 load of HCl is
eliminated by titration with the HCO3
2
produced with NH4
1 (solid rectangle) and
NH4
1 are excreted with Cl2.
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the distal nephron in prolonged fasting could make endogenous
aldosterone a kaliuretic hormone. When NaHCO3 was infused,
and although the rate of excretion of Na1 was similar to that when
equimolar NaCl was given, there was a much greater kaliuresis
(Fig. 4) [33]. Therefore, a decreased distal delivery of HCO3
2
could be an important factor that limits the kaliuresis during
prolonged fasting. In more detail, aldosterone acts primarily on
the principal cell of the CCD where it leads to a more ‘open’
epithelial Na1 ion channel (ENaC) in the luminal membrane [58].
If Cl2 ions are reabsorbed along with Na1 ions, this system will
defend the ECF volume and be absolutely beneficial for survival
(electroneutral reabsorption for Na1; Fig. 5). On the other hand,
if Na1 ions were reabsorbed without Cl2 ions (that is, electro-
genic reabsorption of Na1; Fig. 5), a lumen-negative electrical
potential will be generated in the CCD and this could result in
secretion of K1. Hence, it is important to have a mechanism in
place that will determine if the aldosterone stimulated Na1
reabsorption in the CCD would be “electroneutral” or “electro-
genic” based on the need to defend the ECF volume or to secrete
K1.
We suggest that a low distal delivery of HCO3
2 could limit the
kaliuretic effect of aldosterone and allow this hormone to exert its
NaCl-retaining effect without the risk of undue kaliuresis. This
“cross-talk” between the proximal and distal nephron in which
HCO3
2 reabsorption in the PCT is correlated with the ‘need’ to
secrete K1 in the CCD [59] is consistent with the known influence
of hypokalemia to stimulate and that of hyperkalemia to inhibit
proximal reabsorption of HCO3
2 [60, 61]. It is also important to
recall that there are two physiologic stimuli for the release of
aldosterone. One is a low effective circulating volume; here the
release of aldosterone is stimulated by the product of the renin-
angiotensin system, angiotensin II. The other is hyperkalemia,
which stimulates the release of aldosterone from the zona glo-
merulosa directly (Fig. 6). Therefore, when aldosterone is to
function as a hormone, which should enhance the electroneutral
reabsorption of NaCl, having angiotensin II as its secretagogue
seems to be a logical choice because angiotensin II stimulates
reabsorption of HCO3
2 by the PCT [62, 63] and also by the distal
tubule [64]. Hence, this secretagogue for aldosterone acts also to
diminish its kaliuretic effect by lowering distal delivery of HCO3
2,
if HCO3
2 and/or luminal pH plays an important role in selecting
the electrogenic mode of reabsorption of Na1 in the CCD. In
contrast, when aldosterone is needed to promote the excretion of
K1, having hyperkalemia as its secretagogue also seems logical.
Hyperkalemia not only stimulates the release of aldosterone, but
it also augments the delivery of HCO3
2 to the distal nephron by
diminishing its reabsorption in the PCT (Fig. 6).
The next aspect to explore is which factors might limit distal
delivery of HCO3
2 and hence prevent an excessive kaliuresis
during prolonged fasting. We have already considered the roles of
contraction of the ‘effective’ ECF volume and angiotensin II as
factors that enhance proximal and distal reabsorption of HCO3
2.
Fig. 4. Effect of Na1 and HCO32 on K
1 excretion in prolonged fasting.
Obese subjects fasted for two weeks. One group received an infusion of 2
liters of 150 mM NaCl 1 40 mM KCl over six hours; the second group
received an infusion of 2 liters of 75 mM NaCl 1 75 mM NaHCO3 1 40 mM
KCl over six hours. Results are reported as the mean 6 SEM. (A) The
numbers above the bars are Na1 excretion/hr. (B) The numbers above the
bars are the urine pH values. Data are from [33]. The abbreviation TTKG
is transtubular K1 concentration gradient.
Fig. 5. Electroneutral and electrogenic reabsorption of Na1. The cylin-
der-shaped structure is the cortical collecting duct. When Na1 and Cl2
ions are reabsorbed in equimolar amounts, there is no electrical driving
force to favor net secretion of K1; this is termed electroneutral on the left
side. In contrast, as depicted on the right side of the figure, reabsorption
of Na1 without Cl2 ions is electrogenic [1] and generates the electrical
driving force for net secretion of K1 via K1 ion channels [2].
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A mild degree of K1 depletion could also contribute by augment-
ing proximal reabsorption of HCO3
2 even further [61, 65].
Perhaps there is a physiological advantage for maintaining a lower
plasma HCO3
2 concentration (mild degree of metabolic acidosis)
during prolonged fasting, because this will lower the filtered load
of HCO3
2 and stimulate its reabsorption in the PCT and the
distal nephron [reviewed in 66]. In fact, Stinebaugh and Schloeder
[67] demonstrated a markedly enhanced capacity for reabsorption
of HCO3
2 in prolonged fasting. Moreover, having a lower plasma
[HCO3
2] will prevent a transient alkalemia that could occur if
there was a cephalic phase of gastric secretion of HCl [reviewed in
68].
In prolonged fasting, distal delivery of Na1 is accompanied by
b-HB2 anions and reabsorption of Na1 would, at first glance, be
expected to produce a kaliuresis. We speculate that an additional
mechanism could oppose this unwanted kaliuresis. To the extent
that K1 are secreted in the CCD, they could be reabsorbed
downstream in the medullary collecting duct (MCD) because the
excretion of K1 has been found to be low in prolonged fasting
even when NaCl was infused (Fig. 4). The K1/H1-ATPase can
carry out this function [69], albeit at a cost of extra ATP turnover.
For this process to function, there must be a luminal H1 ion
acceptor, and in this case, the acceptor for H1 is NH3. The net
result would be the excretion of NH4
1 and b-HB2 in a 1:1
stoichiometry while minimizing a further deficit of Na1 or K1.
Issues related to uric acid excretion
The daily excretion of total urates in the fed state is 400 to 450
mg/day [19]. This poses a special challenge because of the risk of
precipitation of uric acid stones. Uric acid is sparingly soluble:
only about 90 mg will dissolve in 1 liter of water at 37°C [70, 71].
The pK of uric acid is close to 5.3 in urine [reviewed in 70]. As
emphasized above, during the first several days of fasting, the
urine pH is low as acidosis stimulates distal H1 secretion (Table
Fig. 6. Aldosterone and the augmented
reabsorption of NaCl. Distal delivery of HCO3
2
augments K1 excretion if aldosterone leads to
an ‘open’ Na1 ion channel in the cortical
collecting duct (CCD). When angiotensin II
causes aldosterone release, reabsorption of
HCO3
2 is stimulated in the proximal
convoluted tubule (PCT) and distal convoluted
tubule (DCT) so delivery of HCO3
2 to the
CCD is small and there is little kaliuresis.
Hyperkalemia, by depressing proximal
reabsorption of HCO3
2, allows the aldosterone
(release stimulated by hyperkalemia) to
promote the electrogenic reabsorption of Na1
in the CCD because of distal delivery of
HCO3
2 and thereby its kaliuretic effect
(Fig. 5).
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1), while there is a lag period before ammoniagenesis is aug-
mented. With this low urine pH, there is increased risk of uric acid
precipitation. Therefore, having the effect of the rise in [b-HB2]
to attenuate the excretion of urate at this stage is a desirable
adaptation (Table 1). Furthermore, a higher urine volume sec-
ondary to the initial natriuresis would also help to maintain the
concentration of uric acid to lower than its solubility product
constant (Ksp).
As fasting continues, this effect of b-HB2 anions to inhibit the
excretion of uric acid diminishes (Table 1), perhaps because of a
higher filtered load of b-HB2 anions [19]. Furthermore, water
conservation is of extreme importance for survival, so another
mechanism is needed to prevent the formation of uric acid stones
during prolonged fasting as long as the daily excretion remains
constant. The leverage here is on adjusting the urine pH. Raising
the urine pH towards 6.0 will mean that only 20% of urinary uric
acid plus urate salts will be in the more sparingly soluble uric acid
form. If the urine volume was 1 liter per day, a fasted subject could
excrete 90 mg of uric acid (1 360 mg urate, total 450 mg/day)
without exceeding the Ksp. Therefore, having a limit on distal H1
secretion in prolonged fasting serves the purpose of decreasing
the risk of uric acid stone formation.
The excretion of uric acid places another demand on humans
during prolonged fasting, the requirement for the excretion of a
volume of urine that is “high enough” to prevent the precipitation
of uric acid. Since a lack of water is a more pressing immediate
challenge to survival than is a lack of food [1, 72, 73], it is obvious
that water conservation must have the highest priority. Neverthe-
less, a critical minimum urine volume must be excreted despite
the fact that ADH will be acting. This aspect will be discussed
below.
Issues related to water
There are two issues with regard to water balance during
prolonged fasting. On the one hand, the aim is to excrete as little
water as possible, but excessive oliguria must be avoided so that
waste products can be excreted [74, 75]. To guarantee a minimum
urine volume while ADH acts, ‘effective’ osmoles must be ex-
creted (equation 2). Since there also must be maximum conser-
vation of Na1 and K1 at this point, the majority of the osmoles in
the urine are b-HB2, NH4
1 and urea. The excretion of NH4
1
salts provides four times the number of solutes as compared to the
excretion of urea for the same nitrogen loss [urea is synthesized
from 2 NH4
1 and 2 HCO3
2 (or potential HCO3
2 5 b-HB2)].
Hence, excreting NH4
1 (150 mmoles per day) with ketoacid
anions (150 mmoles per day) accounts for the needed 300
mOsm/day to excrete 0.5 liter of urine with an ‘effective’ osmola-
lity of close to 600 mOsm/kg H2O [74, 75]; this nitrogen excretion
is the consequence of a net loss of only close to 60 g of muscle per
day. In contrast, the excretion of 0.5 liters of urine per day at the
same osmolality of 600 mOsm/kg H2O would require the catab-
olism of 240 g of muscle if the nitrogenous waste excreted was
only urea [76]. This loss of 1/2 pound of muscle per day (1 kg/4
days) could not be sustained because excessive weakness would
develop and compromise the ability to survive.
To summarize, as long as the same amount of NH4
1 is excreted
with b-HB2 anions, near anuria will be avoided when ADH acts.
Notwithstanding, if the urine pH had declined to less than 5, many
of the b-HB2 anions would be excreted as b-hydroxybutyric acid
(pK 4.7). Although this will be equivalent in acid-base terms to
excreting NH4
1 with b-HB2, excreting the free acid rather than
its NH4
1 salt would obligate only half as much water excretion (1
vs. 2 urinary particles) when ADH acts.
CONCLUSIONS
The integrative aspects of the response to prolonged food and
water deprivation were stressed. Our goals have been to synthe-
size knowledge of known important control mechanisms, and to
develop concepts that may find application ‘at the bedside.’
Energy metabolism
From the perspective of integrative physiology, ketonuria dur-
ing prolonged fasting is not simply a ‘waste of energy’ because it
ensures a necessary minimum urine volume to allow the excretion
of waste products even if there is a water deficit.
Acid-base balance
The lower rate of excretion of NH4
1 during prolonged fasting
is the result of a lower rate of production of NH4
1 due primarily
to the oxidation of ketoacid anions in the kidney. This relatively
lower rate of excretion of NH4
1 may have the advantage of
conserving lean body mass. Further, maintaining a degree of
metabolic acidosis may be beneficial with regard to diminishing
the excretion of K1. Nevertheless, even with this constraint on the
rate of excretion of NH4
1, the kidney has a defense against a
further acid load by controlling the rate of excretion of b-HB2.
The low delivery of Na1 to the distal nephron limits H1 secretion.
Sodium
The natriuresis of early fasting is valuable because it ensures a
large urine volume when the urine pH is low and thereby
minimizes the risk of uric acid stone formation. Moreover, the
large deficit of Na1 is useful later in fasting because it leads to a
high avidity for Na1 in the proximal nephron; the low distal
delivery of Na1 limits distal H1 and K1 secretion. In the former
case, the net effect is a higher urine pH and a lesser risk of a high
concentration of sparingly soluble uric acid. Nevertheless, the
higher urine pH does not result in a rate of excretion of NH4
1
that was lower than that of ketoacid anions. Despite this large
natriuresis, the intravascular volume could be defended by the
effect of angiotensin II to stimulate the release of erythropoietin
and hence maintain the RBC mass.
Potassium
Many of the above events are crucial for K1 homeostasis. A low
rate of excretion of K1 is ensured by having a low distal delivery
of Na1 and HCO3
2. The latter is due to the high angiotensin II
levels in response to ECF volume contraction, a small degree of
hypokalemia, and a low filtered load of HCO3
2. Angiotensin II
enhances the reabsorption of HCO3
2 in proximal and distal
nephron segments, and this could permit aldosterone in this
setting to function as an NaCl-retaining hormone rather than a
kaliuretic hormone. This provides a rationale for the fact that
angiotensin II is a secretagogue for aldosterone when the ECF
volume is low.
Water
When water intake is limited, an adequate urine volume
depends on the excretion of ‘effective’ osmoles, ketoacid anions
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with NH4
1 in this setting. This could help minimize the risk of uric
acid stone formation.
Uric acid
To defend against too high a concentration of uric acid in the
urine, the adaptive mechanisms include parallel changes in the
rate of excretion of total urates and the urine pH, and the need to
ensure an adequate urine volume despite ADH actions when the
urine pH is low. The former utilizes a biphasic effect of b-HB2 on
renal urate reabsorption and the latter is the result of ensuring an
adequate solute excretion rate (Na1 plus K1 salts earlier on and
NH4
1 plus b-HB2 later on). The low distal delivery of Na1 later
on in fasting causes the urine pH to rise towards 6 and hence
lower the concentration of the sparingly soluble uric acid moiety.
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APPENDIX
Abbreviations used in this article are: ADH, antidiuretic hormone;
ATP, adenosine triphosphate; B-HB2, B-hydroxybutyrate; CCD, cortical
collecting duct; ECF, extracellular fluid; ENaC, epithelial Na1 ion chan-
nel; GFR, glomerular filtration rate; MCD, medullary collecting duct;
NH4
1, ammonium; PCT, proximal convoluted tubule; RBC, red blood
cell; RTA, renal tubular acidosis; TTKG, transtubular K1 concentration
gradient.
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